Related Experiment Video
Updated: Mar 3, 2026

Author Spotlight: In Vivo Assessment of Thyroid Hormone Disruption Using the THAI Mouse Model
Published on: October 6, 2023
Changes in Hepatic TRβ Protein Expression, Lipogenic Gene Expression, and Long-Chain Acylcarnitine Levels During
Kenji Ohba1, Rohit Anthony Sinha1, Brijesh Kumar Singh1
11 Cardiovascular and Metabolic Disorders Program, Duke-NUS Medical School , Singapore, Singapore .
Background:
Thyroid hormone (TH) has important roles in regulating hepatic metabolism. It was previously reported that most hepatic genes activated by a single triiodothyronine (T3) injection became desensitized after multiple injections, and that approximately 10% of target genes did not return to basal expression levels after T3 withdrawal, despite normalization of serum TH and thyrotropin (TSH) levels. To determine the possible mechanism(s) for desensitization and incomplete recovery of hepatic target gene transcription and their effects on metabolism, mRNA and/or protein expression levels of key regulators of TH action were measured, as well as metabolomic changes after chronic T3 treatment and withdrawal.
Methods:
Adult male mice were treated with daily injections of T3 (20 μg/100 g body weight) for 14 days followed by the cessation of T3 for 10 days. Livers were harvested at 6 hours, 24 hours, and 14 days after the first T3 injection, and at 10 days after withdrawal, and then analyzed by quantitative reverse transcription polymerase chain reaction, Western blotting, and metabolomics.
Results:
Although TH receptor (TRα and TRβ) mRNAs decreased slightly after chronic T3 treatment, only TRβ protein decreased before returning to basal expression level after withdrawal. The expression of other regulators of TH action was unchanged. TRβ protein expression was also decreased in adult male monocarboxylate transporter-8 (Mct8)-knockout mice, an in vivo model of chronic intrahepatic hyperthyroidism. Previously, increased hepatic long-chain acylcarnitine levels were found after acute TH treatment. However, in this study, long-chain acylcarnitine levels were unchanged after chronic T3, and paradoxically increased after T3 withdrawal. Pathway analyses of the previous microarray results showed upregulation of lipogenic genes after acute T3 treatment and withdrawal. Phosphorylation of acetyl-CoA carboxylase also decreased after T3 withdrawal.
Conclusions:
Decreased hepatic TRβ protein expression occurred after chronic T3 exposure in adult male wild-type and Mct8-knockout mice. Gene array pathway and metabolomics analyses showed abnormalities in hepatic lipogenic gene expression and acylcarnitine levels, respectively, after withdrawal, despite normalization of serum TSH and TH levels. These findings may help explain the variable clinical presentations of some patients during hyperthyroidism and recovery, since TRβ protein, target gene expression, and metabolic adaptive changes can occur in individual tissues without necessarily being reflected by circulating TH and TSH concentrations.
Insights
Chronic thyroid hormone (TH) exposure desensitizes hepatic TRβ protein, leading to altered lipogenic gene expression and acylcarnitine levels after withdrawal. These changes persist despite normal thyroid-stimulating hormone (TSH) and TH levels, impacting hepatic metabolism.
Area of Science:
- Endocrinology
- Molecular Biology
- Metabolomics
Background:
- Thyroid hormone (TH) regulates hepatic metabolism, but desensitization and incomplete gene recovery occur after chronic exposure.
- Understanding mechanisms behind hepatic gene desensitization and incomplete recovery is crucial for metabolic regulation.
Purpose of the Study:
- To investigate the mechanisms of desensitization and incomplete recovery of hepatic target gene transcription after chronic TH treatment.
- To assess the effects of these changes on hepatic metabolism.
Main Methods:
- Adult male mice received daily triiodothyronine (T3) injections for 14 days, followed by 10 days of withdrawal.
- Liver tissues were analyzed using quantitative reverse transcription polymerase chain reaction, Western blotting, and metabolomics.
- Monocarboxylate transporter-8 (Mct8)-knockout mice were used to model chronic intrahepatic hyperthyroidism.
Main Results:
- Chronic T3 treatment decreased hepatic TRβ protein, which persisted after withdrawal in wild-type and Mct8-knockout mice.
- Hepatic lipogenic gene expression and acylcarnitine levels showed abnormalities after T3 withdrawal, despite normalized serum TSH and TH.
- Long-chain acylcarnitine levels paradoxically increased after T3 withdrawal, contrasting with acute TH treatment effects.
Conclusions:
- Decreased hepatic TRβ protein expression is a key finding after chronic T3 exposure.
- Abnormalities in hepatic lipogenic gene expression and acylcarnitine levels post-withdrawal highlight tissue-specific metabolic adaptations.
- Findings may explain variable clinical presentations in hyperthyroidism and recovery due to dissociated tissue and circulating hormone levels.

